CMO/CDMOの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2032)
◆英語タイトル:Global CMO/CDMO Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2032
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、CMO/CDMOの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(開発、API制作、処方)、用途別市場規模(製薬業、バイオテクノロジー、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・CMO/CDMOの市場動向
・企業の競争状況、市場シェア
・CMO/CDMOの種類別市場規模(開発、API制作、処方)
・CMO/CDMOの用途別市場規模(製薬業、バイオテクノロジー、その他)
・CMO/CDMOの北米市場規模2016-2027(アメリカ、カナダ)
・CMO/CDMOの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・CMO/CDMOのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・CMO/CDMOの中南米市場規模2016-2027(メキシコ、ブラジル)
・CMO/CDMOの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Recipharm、AMRI3、Patheon、Aenova、Catalent、Amatsigroup、WuXi PharmaTech、Strides Shasun、Piramal、Siegfried)
・結論
【レポートの概要】

At a time when pharmaceutical companies face increasing price pressures around the globe from key payers, including public and government insurance systems, reducing operational expenses is a major driver of outsourcing pharmaceutical manufacturing to CDMOs. Also, an increasing number of pharmaceutical companies are refocusing on their core capabilities and strengths, leading to divestments of in-house manufacturing capacities in some areas and to a gro

Market Analysis and Insights: Global CMO/CDMO Market
The global CMO/CDMO market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CMO/CDMO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CMO/CDMO market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CMO/CDMO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CMO/CDMO market.

Global CMO/CDMO Scope and Market Size
CMO/CDMO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CMO/CDMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Development
API production
Formulation

Segment by Application
Pharmaceutical Industry
Biotechnology
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Recipharm
AMRI3
Patheon
Aenova
Catalent
Amatsigroup
WuXi PharmaTech
Strides Shasun
Piramal
Siegfried

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CMO/CDMO Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Development
1.2.3 API production
1.2.4 Formulation
1.3 Market by Application
1.3.1 Global CMO/CDMO Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Industry
1.3.3 Biotechnology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CMO/CDMO Market Perspective (2016-2027)
2.2 CMO/CDMO Growth Trends by Regions
2.2.1 CMO/CDMO Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CMO/CDMO Historic Market Share by Regions (2016-2021)
2.2.3 CMO/CDMO Forecasted Market Size by Regions (2022-2027)
2.3 CMO/CDMO Industry Dynamic
2.3.1 CMO/CDMO Market Trends
2.3.2 CMO/CDMO Market Drivers
2.3.3 CMO/CDMO Market Challenges
2.3.4 CMO/CDMO Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CMO/CDMO Players by Revenue
3.1.1 Global Top CMO/CDMO Players by Revenue (2016-2021)
3.1.2 Global CMO/CDMO Revenue Market Share by Players (2016-2021)
3.2 Global CMO/CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CMO/CDMO Revenue
3.4 Global CMO/CDMO Market Concentration Ratio
3.4.1 Global CMO/CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CMO/CDMO Revenue in 2020
3.5 CMO/CDMO Key Players Head office and Area Served
3.6 Key Players CMO/CDMO Product Solution and Service
3.7 Date of Enter into CMO/CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CMO/CDMO Breakdown Data by Type
4.1 Global CMO/CDMO Historic Market Size by Type (2016-2021)
4.2 Global CMO/CDMO Forecasted Market Size by Type (2022-2027)

5 CMO/CDMO Breakdown Data by Application
5.1 Global CMO/CDMO Historic Market Size by Application (2016-2021)
5.2 Global CMO/CDMO Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CMO/CDMO Market Size (2016-2027)
6.2 North America CMO/CDMO Market Size by Type
6.2.1 North America CMO/CDMO Market Size by Type (2016-2021)
6.2.2 North America CMO/CDMO Market Size by Type (2022-2027)
6.2.3 North America CMO/CDMO Market Size by Type (2016-2027)
6.3 North America CMO/CDMO Market Size by Application
6.3.1 North America CMO/CDMO Market Size by Application (2016-2021)
6.3.2 North America CMO/CDMO Market Size by Application (2022-2027)
6.3.3 North America CMO/CDMO Market Size by Application (2016-2027)
6.4 North America CMO/CDMO Market Size by Country
6.4.1 North America CMO/CDMO Market Size by Country (2016-2021)
6.4.2 North America CMO/CDMO Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe CMO/CDMO Market Size (2016-2027)
7.2 Europe CMO/CDMO Market Size by Type
7.2.1 Europe CMO/CDMO Market Size by Type (2016-2021)
7.2.2 Europe CMO/CDMO Market Size by Type (2022-2027)
7.2.3 Europe CMO/CDMO Market Size by Type (2016-2027)
7.3 Europe CMO/CDMO Market Size by Application
7.3.1 Europe CMO/CDMO Market Size by Application (2016-2021)
7.3.2 Europe CMO/CDMO Market Size by Application (2022-2027)
7.3.3 Europe CMO/CDMO Market Size by Application (2016-2027)
7.4 Europe CMO/CDMO Market Size by Country
7.4.1 Europe CMO/CDMO Market Size by Country (2016-2021)
7.4.2 Europe CMO/CDMO Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CMO/CDMO Market Size (2016-2027)
8.2 Asia-Pacific CMO/CDMO Market Size by Type
8.2.1 Asia-Pacific CMO/CDMO Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CMO/CDMO Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CMO/CDMO Market Size by Type (2016-2027)
8.3 Asia-Pacific CMO/CDMO Market Size by Application
8.3.1 Asia-Pacific CMO/CDMO Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CMO/CDMO Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CMO/CDMO Market Size by Application (2016-2027)
8.4 Asia-Pacific CMO/CDMO Market Size by Region
8.4.1 Asia-Pacific CMO/CDMO Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CMO/CDMO Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CMO/CDMO Market Size (2016-2027)
9.2 Latin America CMO/CDMO Market Size by Type
9.2.1 Latin America CMO/CDMO Market Size by Type (2016-2021)
9.2.2 Latin America CMO/CDMO Market Size by Type (2022-2027)
9.2.3 Latin America CMO/CDMO Market Size by Type (2016-2027)
9.3 Latin America CMO/CDMO Market Size by Application
9.3.1 Latin America CMO/CDMO Market Size by Application (2016-2021)
9.3.2 Latin America CMO/CDMO Market Size by Application (2022-2027)
9.3.3 Latin America CMO/CDMO Market Size by Application (2016-2027)
9.4 Latin America CMO/CDMO Market Size by Country
9.4.1 Latin America CMO/CDMO Market Size by Country (2016-2021)
9.4.2 Latin America CMO/CDMO Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CMO/CDMO Market Size (2016-2027)
10.2 Middle East & Africa CMO/CDMO Market Size by Type
10.2.1 Middle East & Africa CMO/CDMO Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CMO/CDMO Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CMO/CDMO Market Size by Type (2016-2027)
10.3 Middle East & Africa CMO/CDMO Market Size by Application
10.3.1 Middle East & Africa CMO/CDMO Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CMO/CDMO Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CMO/CDMO Market Size by Application (2016-2027)
10.4 Middle East & Africa CMO/CDMO Market Size by Country
10.4.1 Middle East & Africa CMO/CDMO Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CMO/CDMO Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Recipharm
11.1.1 Recipharm Company Details
11.1.2 Recipharm Business Overview
11.1.3 Recipharm CMO/CDMO Introduction
11.1.4 Recipharm Revenue in CMO/CDMO Business (2016-2021)
11.1.5 Recipharm Recent Development
11.2 AMRI3
11.2.1 AMRI3 Company Details
11.2.2 AMRI3 Business Overview
11.2.3 AMRI3 CMO/CDMO Introduction
11.2.4 AMRI3 Revenue in CMO/CDMO Business (2016-2021)
11.2.5 AMRI3 Recent Development
11.3 Patheon
11.3.1 Patheon Company Details
11.3.2 Patheon Business Overview
11.3.3 Patheon CMO/CDMO Introduction
11.3.4 Patheon Revenue in CMO/CDMO Business (2016-2021)
11.3.5 Patheon Recent Development
11.4 Aenova
11.4.1 Aenova Company Details
11.4.2 Aenova Business Overview
11.4.3 Aenova CMO/CDMO Introduction
11.4.4 Aenova Revenue in CMO/CDMO Business (2016-2021)
11.4.5 Aenova Recent Development
11.5 Catalent
11.5.1 Catalent Company Details
11.5.2 Catalent Business Overview
11.5.3 Catalent CMO/CDMO Introduction
11.5.4 Catalent Revenue in CMO/CDMO Business (2016-2021)
11.5.5 Catalent Recent Development
11.6 Amatsigroup
11.6.1 Amatsigroup Company Details
11.6.2 Amatsigroup Business Overview
11.6.3 Amatsigroup CMO/CDMO Introduction
11.6.4 Amatsigroup Revenue in CMO/CDMO Business (2016-2021)
11.6.5 Amatsigroup Recent Development
11.7 WuXi PharmaTech
11.7.1 WuXi PharmaTech Company Details
11.7.2 WuXi PharmaTech Business Overview
11.7.3 WuXi PharmaTech CMO/CDMO Introduction
11.7.4 WuXi PharmaTech Revenue in CMO/CDMO Business (2016-2021)
11.7.5 WuXi PharmaTech Recent Development
11.8 Strides Shasun
11.8.1 Strides Shasun Company Details
11.8.2 Strides Shasun Business Overview
11.8.3 Strides Shasun CMO/CDMO Introduction
11.8.4 Strides Shasun Revenue in CMO/CDMO Business (2016-2021)
11.8.5 Strides Shasun Recent Development
11.9 Piramal
11.9.1 Piramal Company Details
11.9.2 Piramal Business Overview
11.9.3 Piramal CMO/CDMO Introduction
11.9.4 Piramal Revenue in CMO/CDMO Business (2016-2021)
11.9.5 Piramal Recent Development
11.10 Siegfried
11.10.1 Siegfried Company Details
11.10.2 Siegfried Business Overview
11.10.3 Siegfried CMO/CDMO Introduction
11.10.4 Siegfried Revenue in CMO/CDMO Business (2016-2021)
11.10.5 Siegfried Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ CMO/CDMOの世界市場規模・現状・予測2021年-2027年(Global CMO/CDMO Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。